Russia's R-Pharm Group eyes expansion in Southeast Asia

R-Pharm Group, one of Russia’s leading pharmaceutical producers, is expanding into the market Southeast Asia, according to the company, reports The Pharma Letter’s local correspondent.

So far, the company has already opened a representative office in Vietnam, according to Andrey Burkhanov, commercial director of the company. He said that the company will register and promote a portfolio of its own drugs in Vietnam, and then in other Southeast Asian countries. Among the other potential destinations for expansion are also Cambodia, Indonesia and Malaysia.

To launch Coronavir and Artlegia